In the last trading session, the stock price of Fitbit Inc (NYSE:FIT) declined more than 2% to close the day at $5.98. Despite the decline noted in the last trading session, the stock has posted gains of more than 4% so far in this year. The traded share volume in the last session stood at $5.32 million compared to average share volume of 5.70 million.
In the month of December, Fitbit and AliphCom LLC, reported that they have reached an international settlement deal resolving all pending litigation between the firms. The terms of the deal will remain confidential and both firms look forward to putting these concerns behind them. Earlier in the month of November, the company reported that it has been finalized as the first wearable for use in the “National All of Us” research plan advanced by the White House in 2015. This assignment is supported by a supplement to a funding award from the NIH to TSRI.
All of Us intends to register one million or more members to support research that may enhance the ability to treat and prevent disease depending on distinct characteristics. Researchers will utilize data collected from the program to know more about the way individual differences in environment, biological and lifestyle makeup can impact health and disease.
As a subdivision of the All of Us, the STSI directs The Participant Center, a segment tasked with engaging and enrolling varied populations across the nation. Using this network, STSI will offer up to 10,000 Fitbit Alta HR™ and Fitbit Charge 2™ devices to a representative sample of “All of Us” volunteers for one-year study. At the close of the research, the professionals will offer recommendations on the way the devices could be broadly used into the much buzzed All of Us Research Plan.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of USmarketsDaily.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: